Trading Signals: BAX Stock Price Prediction and Forecast (Mon. Dec. 1, 2014 - Wed. Sep. 27, 2023)(Baxter International Inc.)
| BAX latest price $56.3700 (-2.32%) ($55.9600 - $57.7000) on Thu. Oct. 6, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.24% (three month average) | RSI | 42 | Latest Price | $56.3700(-2.32%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BAX advances 0.4% a day on average for past five trading days. | Weekly Trend | BAX declines -0.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support BAX advance at 0% a week (0% probability) BLOK(31%) VT(28%) XLK(27%) VUG(26%) VYM(26%) | Factors Impacting BAX price | BAX will decline at least -1.12% in a week (0% probabilities). UUP(-18%) VIXM(-15%) TLT(-3%) TBT(1%) VXX(2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.12% (StdDev 2.24%) | Hourly BBV | -1.7 () | Intraday Trend | -2% | | | |
|
Resistance Level | $56.73 | 5 Day Moving Average | $56.2(0.3%) | 10 Day Moving Average | $55.7(1.2%) | 20 Day Moving Average | $56.73(-0.63%) | To recent high | -15.6% | To recent low | 4.7% | Market Cap | $28.759b | | | | Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems; and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL. |